These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pathogenesis of Intestinal Fibrosis in Inflammatory Bowel Disease and Perspectives for Therapeutic Implication. Bettenworth D; Rieder F Dig Dis; 2017; 35(1-2):25-31. PubMed ID: 28147352 [TBL] [Abstract][Full Text] [Related]
5. Stromal Cell Regulation of Intestinal Inflammatory Fibrosis. Yang W; Yu T; Cong Y Cell Mol Gastroenterol Hepatol; 2024; 17(5):703-711. PubMed ID: 38246590 [TBL] [Abstract][Full Text] [Related]
6. The role of cytokine and immune responses in intestinal fibrosis. Yang B; Zhang G; Elias M; Zhu Y; Wang J J Dig Dis; 2020 Jun; 21(6):308-314. PubMed ID: 32410365 [TBL] [Abstract][Full Text] [Related]
7. Role of non-inflammatory factors in intestinal fibrosis. Zhao JF; Ling FM; Li JR; Chen YD; Huang L; Zhu LR J Dig Dis; 2020 Jun; 21(6):315-318. PubMed ID: 32406603 [TBL] [Abstract][Full Text] [Related]
8. Preventing fibrosis in IBD: update on immune pathways and clinical strategies. Wang J; Yang B; Chandra J; Ivanov A; Brown JM; Rieder F Expert Rev Clin Immunol; 2024 Jul; 20(7):727-734. PubMed ID: 38475672 [TBL] [Abstract][Full Text] [Related]
9. Cellular and Molecular Mechanisms of Intestinal Fibrosis. Wu X; Lin X; Tan J; Liu Z; He J; Hu F; Wang Y; Chen M; Liu F; Mao R Gut Liver; 2023 May; 17(3):360-374. PubMed ID: 36896620 [TBL] [Abstract][Full Text] [Related]
15. Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy. Wang Y; Huang B; Jin T; Ocansey DKW; Jiang J; Mao F Front Immunol; 2022; 13():835005. PubMed ID: 35370998 [TBL] [Abstract][Full Text] [Related]
16. Can we prevent, reduce or reverse intestinal fibrosis in IBD? Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440 [TBL] [Abstract][Full Text] [Related]
17. Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition. Macias-Ceja DC; Mendoza-Ballesteros MT; Ortega-Albiach M; Barrachina MD; Ortiz-Masià D Front Cell Dev Biol; 2023; 11():1258843. PubMed ID: 37822869 [TBL] [Abstract][Full Text] [Related]
18. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Rieder F; Fiocchi C Curr Opin Gastroenterol; 2008 Jul; 24(4):462-8. PubMed ID: 18622160 [TBL] [Abstract][Full Text] [Related]
19. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Wang J; Lin S; Brown JM; van Wagoner D; Fiocchi C; Rieder F Immunol Rev; 2021 Jul; 302(1):211-227. PubMed ID: 33993489 [TBL] [Abstract][Full Text] [Related]